Subcutaneous Allergen Immunotherapy in Patient with “Local Allergic Rhinitis” Sensitized to Dermatophagoides Pteronyssinus

2015 ◽  
Vol 135 (2) ◽  
pp. AB171 ◽  
Author(s):  
Carmen Rondon ◽  
Paloma Campo ◽  
Natalia Blanca-López ◽  
Maria Del Carmen Plaza Seron ◽  
Francisca Gómez ◽  
...  
Keyword(s):  
Allergic Rhinitis ◽  
Allergen Immunotherapy ◽  
Dermatophagoides Pteronyssinus ◽  
Local Allergic Rhinitis

scholarly journals Clinical changes induced by allergen immunotherapy with dermatophagoides pteronyssinus in local allergic rhinitis

2015 ◽  
Vol 5 (Suppl 4) ◽  
pp. O4
Author(s):  
Carmen Rondon ◽  
Paloma Campo ◽  
Maria Torres ◽  
Luisa Galindo ◽  
Natalia Blanca-Lopez ◽  
...  
Keyword(s):  
Allergic Rhinitis ◽  
Allergen Immunotherapy ◽  
Dermatophagoides Pteronyssinus ◽  
Local Allergic Rhinitis ◽  
Clinical Changes

scholarly journals Subcutaneous allergen immunotherapy with dermatophagoides pteronyssinus in patient with local allergic rhinitis

2015 ◽  
Vol 8 ◽  
pp. A263
Author(s):  
Carmen Rondon ◽  
Paloma Campo ◽  
Natalia Blanca-López ◽  
Francisca Gomez ◽  
Maria Dolores Ruiz ◽  
...  
Keyword(s):  
Allergic Rhinitis ◽  
Allergen Immunotherapy ◽  
Dermatophagoides Pteronyssinus ◽  
Local Allergic Rhinitis

scholarly journals Local allergic rhinitis - a big challenge in clinical practice

2021 ◽  
pp. 32-32
Author(s):  
Rajica Stosovic ◽  
Vesna Tomic-Spiric
Keyword(s):  
Allergic Rhinitis ◽  
Gold Standard ◽  
Allergen Immunotherapy ◽  
Provocation Test ◽  
Pharmacological Therapy ◽  
Local Allergic Rhinitis ◽  
Natural Progression ◽  
Allergen Provocation ◽  
Preventive Effects ◽  
Progressive Course

Local allergic rhinitis is a new rhinitis phenotype characterized by symptoms similar to allergic rhinitis, in non-atopic patients with a positive nasal allergen provocation test (NAPT). The disease is diagnosed in over 25% of non-atopic patients with rhinitis, marked as non-atopic rhinitis. It most often has perennial and severe symptoms and a progressive course. It is often associated with conjunctivitis and/or asthma. It is necessary to consider local allergic rhinitis in patients with non-atopic rhinitis. The gold standard for diagnosis is positive NAPT. Pharmacological therapy fails to stop the natural progression and development of comorbidities. Allergen immunotherapy reduces the symptoms, consumption of medicines and increases the tolerance to allergens responsible for local allergic rhinitis. New studies are needed to confirm curative and evaluate the preventive effects of allergen immunotherapy.

Allergen immunotherapy against house dust mites in patients with local allergic rhinitis and asthma

2021 ◽  
pp. 1-11
Author(s):  
Andrzej Bozek ◽  
Beata Galuszka ◽  
Radosław Gawlik ◽  
Maciej Misiolek ◽  
Wojciech Ścierski ◽  
...  
Keyword(s):  
Allergic Rhinitis ◽  
House Dust ◽  
Allergen Immunotherapy ◽  
House Dust Mites ◽  
Dust Mites ◽  
Local Allergic Rhinitis

scholarly journals Experimental Allergen Immunotherapy with Monomeric Allergoid From House Dust Mite Dermatophagoides pteronyssinus in a Mouse Model of Allergic Rhinitis

2018 ◽  
Vol 141 (2) ◽  
pp. AB70
Author(s):  
Alexander A. Babakhin ◽  
Anton A. Laskin ◽  
Oleg Y. Kamishnikov ◽  
Denis G. Chuvirov ◽  
Svetlana V. Khlgatyan ◽  
...  
Keyword(s):  
Allergic Rhinitis ◽  
Mouse Model ◽  
House Dust ◽  
House Dust Mite ◽  
Allergen Immunotherapy ◽  
Dermatophagoides Pteronyssinus ◽  
Dust Mite
Sign in / Sign up

Export Citation Format

Share Document